carbamazepine has been researched along with Multiple Sclerosis in 75 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Carbamazepine (CBZ) is widely used in MS to control pain." | 7.78 | Comparison of carbamazepine rash in multiple sclerosis and epilepsy. ( Alvestad, S; Brodtkorb, E; Espeset, K; Hovdal, H; Lydersen, S; Shirzadi, M, 2012) |
| " These patients were often on carbamazepine treatment before the procedure, a regimen known to cause severe side effects and increase pre-existing symptoms in patients with multiple sclerosis." | 7.67 | Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection. ( Håkanson, S; Linderoth, B, 1989) |
| "Nine cases of multiple sclerosis with paroxysmal disorders were treated with acetazolamide." | 7.65 | Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis. ( Alecu, C; Pruskauer-Apostol, B; Voiculescu, V, 1975) |
| "Oxcarbazepine (OXC) is an anitepileptic medication recently approved as monotherapy for partial onset seizure and demonstrated to be useful in the treatment of several neuropathic pain." | 6.73 | Oxcarbazepine for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. ( Mancardi, GL; Restivo, D; Solaro, C; Tanganelli, P, 2007) |
| "Actuarial recurrence rates were 50% at 12 months and 60% at 24 months." | 6.43 | Percutaneous retrogasserian glycerol rhizotomy in the treatment of tic douloureux associated with multiple sclerosis. ( Bisnaire, D; Ferguson, GG; Pickett, GE, 2005) |
| " Carbamazepine and oxcarbazepine were not immunosuppressive in lymphocyte-driven autoimmunity, but slowed the accumulation of disability in experimental autoimmune encephalomyelitis when administered during periods of the inflammatory penumbra after active lesion formation, and was shown to limit the development of neurodegeneration during optic neuritis in myelin-specific T cell receptor transgenic mice." | 3.80 | Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis. ( Al-Izki, S; Amor, S; Baker, D; Browne, L; Clutterbuck, L; Edith Chan, AW; Garthwaite, J; Gerritsen, WH; Giovannoni, G; Hankey, DJ; Joel, SP; Lidster, K; Montoya, A; Peferoen-Baert, R; Perkins, V; Posada, C; Pryce, G; Selwood, DL; Ummenthum, K; van der Valk, P; von Kutzleben, SM, 2014) |
| " Carbamazepine (CBZ) is widely used in MS to control pain." | 3.78 | Comparison of carbamazepine rash in multiple sclerosis and epilepsy. ( Alvestad, S; Brodtkorb, E; Espeset, K; Hovdal, H; Lydersen, S; Shirzadi, M, 2012) |
| " These patients were often on carbamazepine treatment before the procedure, a regimen known to cause severe side effects and increase pre-existing symptoms in patients with multiple sclerosis." | 3.67 | Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection. ( Håkanson, S; Linderoth, B, 1989) |
| "Nine cases of multiple sclerosis with paroxysmal disorders were treated with acetazolamide." | 3.65 | Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis. ( Alecu, C; Pruskauer-Apostol, B; Voiculescu, V, 1975) |
| "Oxcarbazepine (OXC) is an anitepileptic medication recently approved as monotherapy for partial onset seizure and demonstrated to be useful in the treatment of several neuropathic pain." | 2.73 | Oxcarbazepine for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. ( Mancardi, GL; Restivo, D; Solaro, C; Tanganelli, P, 2007) |
| "Trigeminal neuralgia is one of the most characteristic and difficult to treat neuropathic pain conditions in patients with multiple sclerosis." | 2.61 | Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options. ( Di Stefano, G; Maarbjerg, S; Truini, A, 2019) |
| "Actuarial recurrence rates were 50% at 12 months and 60% at 24 months." | 2.43 | Percutaneous retrogasserian glycerol rhizotomy in the treatment of tic douloureux associated with multiple sclerosis. ( Bisnaire, D; Ferguson, GG; Pickett, GE, 2005) |
| "Classically, trigeminal neuralgia has been described as a paroxysmal, lancinating, knifelike pain which is limited to the anatomic pathways of the fifth cranial nerve." | 2.36 | Trigeminal neuralgia: an overview. ( Bayer, DB; Stenger, TG, 1979) |
| "Multiple sclerosis is a common inflammatory demyelinating disease of the central nervous system." | 1.62 | [Paroxysmal dysarthria and ataxia - unusual MS manifestation]. ( Morar, F; Papastergios, C; Schiopu-Mariean, BL; Shaker, A, 2021) |
| "Median age at the first seizure (before or after MS) was 41 years (range 0-80)." | 1.48 | Treatment of epilepsy in multiple sclerosis. ( Burman, J; Dagiasi, I; Kumlien, E; Vall, V; Zelano, J, 2018) |
| "Treatment with carbamazepine resulted in the complete reversal of the paroxysmal ataxia and dysarthria." | 1.40 | Paroxysmal ataxia and dysarthria in multiple sclerosis. ( Batocchi, AP; Capone, F; Iorio, R; Plantone, D, 2014) |
| "Multiple sclerosis is an immune-mediated, demyelinating and neurodegenerative disease that currently lacks any neuroprotective treatments." | 1.39 | Neuroprotection in a novel mouse model of multiple sclerosis. ( Ahmed, Z; Baker, D; Baker, MD; Coffey, P; Giovannoni, G; Jackson, SJ; Lidster, K; Munro, P, 2013) |
| "Paroxysmal dysarthria-ataxia syndrome (PDA) is a rare neurological disorder that can be either primary or symptomatic of acute neurological dysfunction." | 1.36 | Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases. ( Anheim, M; Boulay, C; Flamand-Rouvière, C; Heran, F; Marcel, C; Mari, I; Masnou, P; Roze, E; Tranchant, C, 2010) |
| "Glossopharyngeal neuralgia is a painful condition, affecting the ninth cranial nerve, rarely described in the course of multiple sclerosis." | 1.35 | Glossopharyngeal neuralgia as onset of multiple sclerosis. ( Carrieri, PB; Montella, S; Petracca, M, 2009) |
| "Carbamazepine (CBZ) was prescribed in 36 patients, with adverse effects reported in 20 cases, of which 12 mimicked a relapse." | 1.33 | Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. ( Battaglia, MA; Brichetto, G; Mancardi, GL; Messmer Uccelli, M; Solaro, C, 2005) |
| "All patients with seizures or epilepsy were submitted to standard EEG and brain MRI with gadopentetate dimeglumine." | 1.31 | Seizures in multiple sclerosis. ( Dragutinovic, G; Drulovic, J; Dujmovic, I; Ercegovac, M; Levic, Z; Mesaros, S; Peric, V; Sokic, DV; Stojsavljevic, N, 2001) |
| "Trigeminal neuralgia is an extremely painful affliction of the face that is treated by various specialists including oral and maxillofacial surgeons." | 1.31 | Investigation and medical management of trigeminal neuralgia by consultant oral and maxillofacial surgeons in the British Isles. ( Dewi, PS; Hindle, I; Pemberton, MN; Thornhill, MH, 2001) |
| "Treatment with carbamazepine, an antiepileptic drug, suppressed the attacks including the associated urinary incontinence." | 1.30 | Paroxysmal urinary incontinence associated with multiple sclerosis. ( Nagahama, Y; Ueda, T; Yoshida, O; Yoshimura, N, 1997) |
| "Trigeminal neuralgia is a well-recognized complication in patients with multiple sclerosis." | 1.29 | Trigeminal neuralgia and multiple sclerosis. A complex diagnosis. ( Campbell, MJ; Gale, D; Prime, S, 1995) |
| "Trigeminal neuralgia is one of the paroxysmal symptoms of multiple sclerosis and may appear in the prodromal stage of this degenerative disease." | 1.29 | Trigeminal neuralgia: a cautionary tale. ( Field, EA; Neilson, K, 1994) |
| "A patient with multiple sclerosis is described who presented with a unilateral loss of voluntary function of his lower face muscles." | 1.28 | Automatic-voluntary dissociation: an unusual facial paresis in a patient with probable multiple sclerosis. ( Dichgans, J; Eblen, F; Weller, M, 1992) |
| "Paroxysmal itching is described in three Japanese women with multiple sclerosis and previously reported cases are discussed." | 1.26 | Paroxysmal itching in multiple sclerosis: a report of three cases. ( Hayabara, T; Otsuki, S; Yabuki, S; Yamamoto, M, 1981) |
| "Carbamazepine was successful in arresting the hiccups in one of the cases presented." | 1.26 | Hoquet diabolique: intractable hiccups as a manifestation of multiple sclerosis. ( McFarling, DA; Susac, JO, 1979) |
| "Paroxysmal dysarthria and ataxia (7 cases), and tonic seizures (5 cases) were the most common types of attacks." | 1.25 | Paroxysmal attacks in multiple sclerosis. ( Ostermann, PO; Westerberg, CE, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (49.33) | 18.7374 |
| 1990's | 9 (12.00) | 18.2507 |
| 2000's | 13 (17.33) | 29.6817 |
| 2010's | 15 (20.00) | 24.3611 |
| 2020's | 1 (1.33) | 2.80 |
| Authors | Studies |
|---|---|
| Papastergios, C | 1 |
| Shaker, A | 1 |
| Schiopu-Mariean, BL | 1 |
| Morar, F | 1 |
| Dagiasi, I | 1 |
| Vall, V | 1 |
| Kumlien, E | 1 |
| Burman, J | 1 |
| Zelano, J | 1 |
| Redon, S | 1 |
| Graillon, N | 1 |
| Régis, J | 1 |
| Donnet, A | 1 |
| Di Stefano, G | 1 |
| Maarbjerg, S | 1 |
| Truini, A | 1 |
| Tobin, WO | 1 |
| Iorio, R | 1 |
| Capone, F | 1 |
| Plantone, D | 1 |
| Batocchi, AP | 1 |
| Lidster, K | 2 |
| Jackson, SJ | 1 |
| Ahmed, Z | 1 |
| Munro, P | 1 |
| Coffey, P | 1 |
| Giovannoni, G | 2 |
| Baker, MD | 1 |
| Baker, D | 2 |
| Al-Izki, S | 1 |
| Pryce, G | 1 |
| Hankey, DJ | 1 |
| von Kutzleben, SM | 1 |
| Browne, L | 1 |
| Clutterbuck, L | 1 |
| Posada, C | 1 |
| Edith Chan, AW | 1 |
| Amor, S | 1 |
| Perkins, V | 1 |
| Gerritsen, WH | 1 |
| Ummenthum, K | 1 |
| Peferoen-Baert, R | 1 |
| van der Valk, P | 1 |
| Montoya, A | 1 |
| Joel, SP | 1 |
| Garthwaite, J | 1 |
| Selwood, DL | 1 |
| Counihan, TJ | 1 |
| Duignan, JA | 1 |
| Gormley, G | 1 |
| Saidha, S | 1 |
| Dooley, C | 1 |
| Newell, J | 1 |
| Bogorad, I | 1 |
| Blum, S | 1 |
| Green, M | 1 |
| Carrieri, PB | 1 |
| Montella, S | 1 |
| Petracca, M | 1 |
| Marcel, C | 1 |
| Anheim, M | 1 |
| Flamand-Rouvière, C | 1 |
| Heran, F | 1 |
| Masnou, P | 1 |
| Boulay, C | 1 |
| Mari, I | 1 |
| Tranchant, C | 1 |
| Roze, E | 1 |
| André, MC | 1 |
| Pacheco, D | 1 |
| Antunes, J | 1 |
| Silva, R | 1 |
| Filipe, P | 1 |
| Soares de Almeida, LM | 1 |
| Bittner, S | 1 |
| Höhn, K | 1 |
| Göbel, K | 1 |
| Kleinschnitz, C | 1 |
| Wiendl, H | 1 |
| Meuth, SG | 1 |
| Shirzadi, M | 1 |
| Alvestad, S | 1 |
| Hovdal, H | 1 |
| Espeset, K | 1 |
| Lydersen, S | 1 |
| Brodtkorb, E | 1 |
| Tang, X | 1 |
| Zhang, X | 1 |
| Yates, TJ | 1 |
| Crawley, F | 1 |
| Trinka, E | 1 |
| Unterberger, I | 1 |
| Spiegel, M | 1 |
| Niedermüller, U | 1 |
| Benke, T | 1 |
| Berger, T | 1 |
| Bauer, G | 1 |
| Gil, M | 1 |
| Chizzolini, C | 1 |
| Kaya, G | 1 |
| Hauser, C | 1 |
| Solaro, C | 3 |
| Brichetto, G | 1 |
| Battaglia, MA | 1 |
| Messmer Uccelli, M | 1 |
| Mancardi, GL | 3 |
| Pickett, GE | 1 |
| Bisnaire, D | 1 |
| Ferguson, GG | 1 |
| Restivo, D | 1 |
| Tanganelli, P | 1 |
| Skillrud, DM | 1 |
| Goldstein, NP | 1 |
| Yamamoto, M | 1 |
| Yabuki, S | 1 |
| Hayabara, T | 1 |
| Otsuki, S | 1 |
| Feijoo de Freixo, M | 1 |
| Jiménez García, M | 1 |
| Martínez Muerza, F | 1 |
| Lunar Domínguez, A | 1 |
| Martí-Vilalta, JL | 1 |
| Costa-Jussá, F | 1 |
| Roig, C | 1 |
| Bolden, RO | 1 |
| Felsenthal, G | 1 |
| Cohen, BS | 1 |
| Hooge, JP | 1 |
| Redekop, WK | 1 |
| Gale, D | 1 |
| Prime, S | 1 |
| Campbell, MJ | 1 |
| Neilson, K | 1 |
| Field, EA | 1 |
| Previdi, P | 1 |
| Buzzi, P | 1 |
| Yoshimura, N | 1 |
| Nagahama, Y | 1 |
| Ueda, T | 1 |
| Yoshida, O | 1 |
| Minagar, A | 1 |
| Sheremata, WA | 2 |
| Ramsaransing, G | 1 |
| Zwanikken, C | 1 |
| De Keyser, J | 1 |
| Tacconi, L | 1 |
| Miles, JB | 1 |
| Leandri, M | 1 |
| Lundardi, G | 1 |
| Inglese, M | 1 |
| Messmer-Uccelli, M | 1 |
| Gottlieb, A | 1 |
| Sokic, DV | 1 |
| Stojsavljevic, N | 1 |
| Drulovic, J | 1 |
| Dujmovic, I | 1 |
| Mesaros, S | 1 |
| Ercegovac, M | 1 |
| Peric, V | 1 |
| Dragutinovic, G | 1 |
| Levic, Z | 1 |
| Pemberton, MN | 1 |
| Dewi, PS | 1 |
| Hindle, I | 1 |
| Thornhill, MH | 1 |
| Chen, CS | 1 |
| Lin, SF | 1 |
| Chong, MY | 1 |
| McFarling, DA | 1 |
| Susac, JO | 1 |
| Bayer, DB | 1 |
| Stenger, TG | 1 |
| Wolf, P | 2 |
| Froissart, M | 1 |
| Mizon, JP | 1 |
| Jacquemart, F | 1 |
| Osterman, PO | 2 |
| Zavalishin, IA | 1 |
| Nevskaia, OM | 1 |
| Niiazbekova, AS | 1 |
| Rabinovitch, HE | 1 |
| Sharpe, JA | 1 |
| Sylvester, TO | 1 |
| Ostermann, PO | 1 |
| Westerberg, CE | 1 |
| Voiculescu, V | 1 |
| Pruskauer-Apostol, B | 1 |
| Alecu, C | 1 |
| Eblen, F | 1 |
| Weller, M | 1 |
| Dichgans, J | 1 |
| ten Berg, JM | 1 |
| de Waal, WJ | 1 |
| Mauser, HW | 1 |
| Telischi, FF | 1 |
| Grobman, LR | 1 |
| Apple, M | 1 |
| Ayyar, R | 1 |
| Honig, LS | 1 |
| Wasserstein, PH | 1 |
| Adornato, BT | 1 |
| Linderoth, B | 1 |
| Håkanson, S | 1 |
| Todman, DH | 1 |
| Miró, J | 1 |
| Garcia-Moncó, C | 1 |
| Leno, C | 1 |
| Berciano, J | 1 |
| Sechi, GP | 1 |
| Piras, MR | 1 |
| Demurtas, A | 1 |
| Tanca, S | 1 |
| Rosati, G | 1 |
| Tan, CT | 1 |
| Low, ET | 1 |
| Jacome, DE | 1 |
| Francis, DA | 1 |
| Heron, JR | 1 |
| Assmus, H | 1 |
| Harrison, M | 1 |
| McGill, JI | 1 |
| Cendrowski, W | 2 |
| Miley, CE | 1 |
| Forster, FM | 1 |
| Shibasaki, H | 2 |
| Kuroiwa, Y | 2 |
| Vallat, JN | 1 |
| Gaudin, H | 1 |
| Tapie, P | 1 |
| Vallat, I | 1 |
| Yoshimasu, F | 1 |
| Kurland, LT | 1 |
| Elveback, LR | 1 |
| Aarli, JA | 1 |
| Tyler, HR | 1 |
| Majkowski, J | 1 |
| Redpath, TH | 1 |
| Gayford, JJ | 1 |
| Castaigne, P | 1 |
| Cambier, J | 1 |
| Masson, M | 1 |
| Brunet, P | 1 |
| Lechevallier, B | 1 |
| Delaporte, P | 1 |
| Dehen, H | 1 |
| Espir, ML | 1 |
| Millac, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Orofacial Pain in Multiple Sclerosis[NCT06021561] | 200 participants (Anticipated) | Observational | 2023-09-04 | Recruiting | |||
| OxCarbazepine as a Neuroprotective Agent in MS: A Phase 2a Trial[NCT02104661] | Phase 2 | 30 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| A Phase II Double Blind, Randomized, Placebo Controlled Trial of Neuroprotection With Phenytoin in Acute Optic Neuritis[NCT01451593] | Phase 2 | 92 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for carbamazepine and Multiple Sclerosis
| Article | Year |
|---|---|
Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options.
Topics: Carbamazepine; Decompression, Surgical; Facial Pain; Humans; Magnetic Resonance Imaging; Multiple Sc | 2019 |
Management of Multiple Sclerosis Symptoms and Comorbidities.
Topics: Anticonvulsants; Carbamazepine; Cognitive Dysfunction; Comorbidity; Depression; Disease Management; | 2019 |
[Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications].
Topics: Adult; Aged; Aged, 80 and over; Amines; Anticonvulsants; Antineoplastic Agents; Carbamazepine; Cohor | 2011 |
Percutaneous retrogasserian glycerol rhizotomy in the treatment of tic douloureux associated with multiple sclerosis.
Topics: Adult; Analgesics; Carbamazepine; Combined Modality Therapy; Female; Follow-Up Studies; Glycerol; Hu | 2005 |
Trigeminal neuralgia: an overview.
Topics: Age Factors; Aged; Anesthetics, Local; Carbamazepine; Diagnosis, Differential; Electrocoagulation; F | 1979 |
Advances in neurology.
Topics: Analgesics; Anticoagulants; Brain; Brain Neoplasms; Carbamazepine; Cerebrovascular Disorders; Contra | 1968 |
5 trials available for carbamazepine and Multiple Sclerosis
| Article | Year |
|---|---|
Oxcarbazepine for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.
Topics: Adult; Anticonvulsants; Carbamazepine; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Neural | 2007 |
Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis.
Topics: Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Female; Humans; Lamotrigine; Male; Middle Aged; | 2000 |
Painful tonic seizure in multiple sclerosis.
Topics: Adult; Animals; Brain Stem; Carbamazepine; Cerebellum; Cerebral Cortex; Clinical Trials as Topic; De | 1974 |
Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol).
Topics: Administration, Oral; Adult; Carbamazepine; Dibenzazepines; Female; Humans; Male; Middle Aged; Multi | 1970 |
Painful tonic seizure in multiple sclerosis treatment with diphenylhydantoin and carbamazepine.
Topics: Adult; Carbamazepine; Dibenzazepines; Electrocardiography; Electroencephalography; Female; Humans; M | 1968 |
64 other studies available for carbamazepine and Multiple Sclerosis
| Article | Year |
|---|---|
[Paroxysmal dysarthria and ataxia - unusual MS manifestation].
Topics: Ataxia; Carbamazepine; Dysarthria; Female; Humans; Middle Aged; Multiple Sclerosis | 2021 |
Treatment of epilepsy in multiple sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Disability Evaluation; Electronic He | 2018 |
First Bite Syndrome After Trigeminal Radiosurgery: Case Report and Pathophysiology.
Topics: Adult; Carbamazepine; Cheek; Combined Modality Therapy; Drug Therapy, Combination; Facial Muscles; F | 2018 |
Paroxysmal ataxia and dysarthria in multiple sclerosis.
Topics: Adult; Anticonvulsants; Ataxia; Carbamazepine; Dysarthria; Humans; Male; Multiple Sclerosis | 2014 |
Neuroprotection in a novel mouse model of multiple sclerosis.
Topics: Animals; Anticonvulsants; Carbamazepine; Caspase 2; Disease Models, Animal; Evoked Potentials, Visua | 2013 |
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Specimen Ba | 2014 |
Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study.
Topics: Adult; Carbamazepine; Disability Evaluation; Disease Progression; Female; Humans; Male; Middle Aged; | 2014 |
A case of MS presenting with SUNCT status.
Topics: Anticonvulsants; Brain; Carbamazepine; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; | 2010 |
Glossopharyngeal neuralgia as onset of multiple sclerosis.
Topics: Adult; Anticonvulsants; Carbamazepine; Female; Glossopharyngeal Nerve Diseases; Humans; Immunoglobul | 2009 |
Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Ataxia; Carbamazepine; Demyelinatin | 2010 |
Generalized skin drug eruption to natalizumab in a patient with multiple sclerosis.
Topics: Adult; Amitriptyline; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzodi | 2010 |
Comparison of carbamazepine rash in multiple sclerosis and epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Exanthema; Female; H | 2012 |
Drug-induced pemphigus after six years of treatment with phenytoin and carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Female; Humans; Middle Aged; Multiple Sclerosis; Pemphigus; Phenytoi | 2012 |
Paroxysmal symptoms in multiple sclerosis masquerading as transient ischaemic attacks.
Topics: Anticonvulsants; Carbamazepine; Cerebellar Diseases; Diagnosis, Differential; Electrocardiography; H | 2010 |
De novo aphasic status epilepticus as presenting symptom of multiple sclerosis.
Topics: Adolescent; Aphasia; Apraxias; Carbamazepine; Cerebral Cortex; Diagnosis, Differential; Electroencep | 2002 |
Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
Topics: Adjuvants, Immunologic; Adult; Carbamazepine; Diagnosis, Differential; Erythema; Female; Humans; Int | 2004 |
Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study.
Topics: Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Follow-Up Studies; | 2005 |
Paroxysmal limb hemiataxia with crossed facial paresthesias in multiple sclerosis.
Topics: Adult; Ataxia; Carbamazepine; Face; Humans; Male; Multiple Sclerosis; Paresthesia; Phenytoin; Thromb | 1983 |
Paroxysmal itching in multiple sclerosis: a report of three cases.
Topics: Adult; Blindness; Carbamazepine; Female; Humans; Middle Aged; Multiple Sclerosis; Muscles; Nystagmus | 1981 |
[Painful tonic seizures in multiple sclerosis. Clinical and electromyographic aspects (author's transl)].
Topics: Adult; Calcium; Carbamazepine; Electromyography; Female; Humans; Multiple Sclerosis; Myoclonus | 1981 |
[Multiple sclerosis. Treatment interactions].
Topics: Adult; Baclofen; Carbamazepine; Drug Interactions; Humans; Male; Multiple Sclerosis; Muscle Spastici | 1981 |
Tonic seizures in a patient with multiple sclerosis.
Topics: Carbamazepine; Clonazepam; Female; Humans; Middle Aged; Multiple Sclerosis; Phenytoin; Seizures | 1980 |
Trigeminal neuralgia in multiple sclerosis.
Topics: Adult; Carbamazepine; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Trigeminal Neuralgia | 1995 |
Trigeminal neuralgia and multiple sclerosis. A complex diagnosis.
Topics: Adult; Carbamazepine; Cerebral Veins; Cryosurgery; Humans; Male; Microsurgery; Multiple Sclerosis; N | 1995 |
Trigeminal neuralgia: a cautionary tale.
Topics: Adult; Carbamazepine; Diagnosis, Differential; Humans; Male; Multiple Sclerosis; Trigeminal Neuralgi | 1994 |
Carbamazepine for paroxysmal dystonia due to spinal cord lesions.
Topics: Carbamazepine; Chronic Disease; Dystonia; Humans; Multiple Sclerosis; Spinal Cord Injuries | 1993 |
Paroxysmal urinary incontinence associated with multiple sclerosis.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Electroencephalography; Fem | 1997 |
Glossopharyngeal neuralgia and MS.
Topics: Adult; Carbamazepine; Female; Glossopharyngeal Nerve Diseases; Humans; Male; Middle Aged; Multiple S | 2000 |
Worsening of symptoms of multiple sclerosis associated with carbamazepine.
Topics: Aged; Analgesics, Non-Narcotic; Carbamazepine; Disease Progression; Humans; Male; Middle Aged; Multi | 2000 |
Bilateral trigeminal neuralgia: a therapeutic dilemma.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Charcot-Marie-Tooth Disease; Cryotherapy; Female; Human | 2000 |
Seizures in multiple sclerosis.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Anticonvulsants; Atrophy; Brain; Carbamazepine; | 2001 |
Investigation and medical management of trigeminal neuralgia by consultant oral and maxillofacial surgeons in the British Isles.
Topics: Anticonvulsants; Carbamazepine; Central Nervous System; Head and Neck Neoplasms; Hematopoietic Syste | 2001 |
Charles Bonnet syndrome and multiple sclerosis.
Topics: Anticonvulsants; Carbamazepine; Comorbidity; Female; Hallucinations; Humans; Middle Aged; Multiple S | 2001 |
Hoquet diabolique: intractable hiccups as a manifestation of multiple sclerosis.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Carbamazepine; Female; Hiccup; Humans; Male; Multipl | 1979 |
[Non-epileptic fits in multiple sclerosis].
Topics: Ataxia; Carbamazepine; Dysarthria; Humans; Multiple Sclerosis; Pain; Paresthesia; Seizures; Time Fac | 1979 |
[Paroxysmal motor and sensory-motor manifestations in multiple sclerosis].
Topics: Adult; Carbamazepine; Contracture; Extremities; Female; Follow-Up Studies; Humans; Male; Multiple Sc | 1979 |
Paroxysmal itching in multiple sclerosis.
Topics: Carbamazepine; Female; Humans; Multiple Sclerosis; Pruritus | 1979 |
[Paroxysmal attacks of dysarthria and ataxia in multiple sclerosis].
Topics: Adult; Ataxia; Carbamazepine; Diagnosis, Differential; Dysarthria; Epilepsy; Humans; Male; Multiple | 1978 |
The ocular tilt reaction. A paroxysmal dyskinesia associated with elliptical nystagmus.
Topics: Adult; Carbamazepine; Eye Movements; Head; Humans; Male; Movement Disorders; Multiple Sclerosis; Nys | 1977 |
Paroxysmal itching in multiple sclerosis.
Topics: Adult; Carbamazepine; Female; Humans; Middle Aged; Multiple Sclerosis; Paresthesia; Periodicity; Pru | 1976 |
Paroxysmal attacks in multiple sclerosis.
Topics: Adult; Ataxia; Carbamazepine; Diplopia; Female; Functional Laterality; Humans; Hypesthesia; Male; Mi | 1975 |
Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis.
Topics: Acetazolamide; Adult; Aged; Brain Stem; Carbamazepine; Diplopia; Female; Humans; Hypesthesia; Male; | 1975 |
Automatic-voluntary dissociation: an unusual facial paresis in a patient with probable multiple sclerosis.
Topics: Adult; Brain; Carbamazepine; Facial Expression; Facial Muscles; Facial Paralysis; Functional Lateral | 1992 |
[Paroxysmal symptoms as initial expression of multiple sclerosis].
Topics: Adult; Carbamazepine; Diplopia; Dysarthria; Female; Gait; Humans; Multiple Sclerosis; Muscle Cramp; | 1992 |
Hemifacial spasm. Occurrence in multiple sclerosis.
Topics: Adrenocorticotropic Hormone; Adult; Brain; Carbamazepine; Electromyography; Facial Muscles; Facial P | 1991 |
Tonic spasms in multiple sclerosis. Anatomic basis and treatment.
Topics: Adult; Arm; Carbamazepine; Facial Muscles; Facial Paralysis; Humans; Hyperventilation; Leg; Male; Mu | 1991 |
Paroxysmal facial pain in disseminated sclerosis treated by retrogasserian glycerol injection.
Topics: Adult; Aged; Carbamazepine; Facial Pain; Female; Glycerol; Humans; Male; Middle Aged; Multiple Scler | 1989 |
A paroxysmal ocular motility disorder in multiple sclerosis.
Topics: Adult; Carbamazepine; Diagnosis, Differential; Eye Movements; Female; Humans; Multiple Sclerosis; Op | 1988 |
Pelvic pain: an undescribed paroxysmal manifestation of multiple sclerosis.
Topics: Adolescent; Carbamazepine; Female; Humans; Multiple Sclerosis; Pain; Pelvis | 1988 |
Dexamethasone-induced schizoaffective-like state in multiple sclerosis: prophylaxis and treatment with carbamazepine.
Topics: Adult; Carbamazepine; Dexamethasone; Female; Humans; Multiple Sclerosis; Psychoses, Substance-Induce | 1987 |
Paroxysmal tonic seizures in demyelinating disease.
Topics: Adult; Carbamazepine; Demyelinating Diseases; Female; Humans; Middle Aged; Multiple Sclerosis; Seizu | 1986 |
La toux diabolique: neurogenic tussive crisis.
Topics: Carbamazepine; Cough; Female; Humans; Middle Aged; Multiple Sclerosis; Valproic Acid | 1985 |
Ocular flutter in suspected multiple sclerosis: a presenting paroxysmal manifestation.
Topics: Adult; Carbamazepine; Eye Movements; Female; Humans; Multiple Sclerosis; Vision Disorders | 1985 |
[Paroxysmal dysarthria and ataxia. A pathognomonic seizure syndrome in multiple sclerosis (author's transl)].
Topics: Adult; Ataxia; Axons; Carbamazepine; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Neurolog | 1974 |
Transient neurological distrubances in disseminated sclerosis: a case report.
Topics: Adrenocorticotropic Hormone; Adult; Ataxia; Carbamazepine; Electroencephalography; Handwriting; Huma | 1969 |
[Paroxysmal ataxia, tonic spasms and paroxysmal paralysis in multiple sclerosis].
Topics: Adrenocorticotropic Hormone; Adult; Body Temperature; Carbamazepine; Cerebellar Ataxia; Electroencep | 1971 |
Paroxysmal signs and symptoms in multiple sclerosis.
Topics: Adrenocorticotropic Hormone; Adult; Ataxia; Brain Stem; Carbamazepine; Diagnosis, Differential; Fema | 1974 |
[Clinical note apropos of 2 recent cases of multiple sclerosis with paroxysmal motor manifestations].
Topics: Adult; Carbamazepine; Female; Humans; Middle Aged; Movement Disorders; Multiple Sclerosis; Neurologi | 1972 |
Tic douloureux in Rochester, Minnesota, 1945-1969.
Topics: Adult; Age Factors; Aged; Analgesics; Carbamazepine; Ethanol; Female; Follow-Up Studies; Humans; Hyp | 1972 |
Carbamazepine (tegretol)--trigeminal neuralgia and other uses.
Topics: Carbamazepine; Epilepsy; Facial Neuralgia; Female; Glossopharyngeal Nerve; Humans; Multiple Sclerosi | 1973 |
[Diagnostic criteria of trigeminal neuralgia-facial pains].
Topics: Age Factors; Carbamazepine; Diagnosis, Differential; Facial Neuralgia; Humans; Hypesthesia; Multiple | 1973 |
Epilepsy in multiple sclerosis.
Topics: Adolescent; Adult; Barbiturates; Basal Ganglia; Carbamazepine; Cerebral Cortex; Demyelinating Diseas | 1972 |
The side effects of carbamazepine therapy.
Topics: Ataxia; Carbamazepine; Depression; Dibenzazepines; Female; Humans; Leukocyte Count; Male; Middle Age | 1968 |
[Paroxysmal motor manifestations in multiple sclerosis].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Female; Humans; Male; Middle Aged | 1970 |